Last reviewed · How we verify

NCT05760014: HYPNOSTRESS

Medical Hypnosis and Stress Reduction in Hospitalization

Completed Last updated 26 December 2025
What this trial tests

trial in Stress in 24 participants. Completed in 9 February 2024.

Timeline
28 March 2023
Primary endpoint
9 February 2024
9 February 2024

Quick facts

Lead sponsorUniversity Hospital, Lille
StatusCompleted
Study typeOBSERVATIONAL
Enrollment24
Start date28 March 2023
Primary completion9 February 2024
Estimated completion9 February 2024
Sites1 location across France

Conditions studied

Sponsor

University Hospital, Lille

Who can join

18 and older, any sex, with Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with chronic diseases, especially rare diseases with uncertain diagnoses, have a representation of their disease and an experience of their hospitalization that is sometimes traumatic, distressing and painful. Patients hospitalized can benefit from non-medicinal techniques, such as medical hypnosis, which could improve the perceived stress in these patients and thus optimize the hospitalization experience. The aim of this study is to evaluate the impact of medical hypnosis in reducing stress and improving the experience of hospitalization comparing two groups : a group (cases) benefiting from an hypnotic technic " the place of safety " and a control group without intervention during hospitalization

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Stress

Currently open trials in the same condition.

Other University Hospital, Lille trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05760014.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing